- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04053504
Feasibility Study of Family Teamwork Peer-Delivery (TEAM)
The purpose of this study is to 1) convene African American and Latino Community Coalitions to adapt Family Teamwork (FT) for school-age youth, and integrate FT with the Smart and Secure Children (SSC) program community-based, peer delivery format, 2) identify facilitators and barriers to parental involvement in diabetes management for African American and Latino parents of children (5-9 years) with T1D to refine, with Community Coalitions the adapted and integrated Family Teamwork- Peer Delivery (FT-P), and 3) evaluate the feasibility, satisfaction, and preliminary outcomes of the FT-P program among African American and Latino parents of school-aged children (5-9 years) withT1D.
A randomized pilot trials will be conducted with African American and Latino families to examine the feasibility, parent satisfaction, and preliminary outcomes of FT-P. Families will be stratified by race/ethnicity, age, and HbA1c strata, and randomized to FT-P plus standard diabetes care or to standard diabetes care alone after completion of baseline assessment using a random numbers table generated by a program created through Baylor College of Medicine's Institute for Clinical Training and Research data management specialists.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary caregiver of a child ages 5-10 years with type 1 diabetes as defined by the American Diabetes Association criteria
- Having a child with diabetes duration of >1 year
- Self-identified African American or Latino race/ethnicity
- Fluent in English
- Not planning to leave the geographic area during the study
Exclusion Criterion:
• Not fluent in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Behavioral intervention delivered by parent peer leaders.
|
Children with T1D and their parent will participate in 6 in-person FT-P group sessions during a 12-month period.
Parents will also participate in monthly telephone support calls with a Parent Leader during the 12-month intervention period.
|
No Intervention: Standard Care
Standard diabetes care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention Acceptability: Treatment Evaluation Inventory
Time Frame: Immediately post-intervention
|
Treatment Evaluation Inventory
|
Immediately post-intervention
|
Study Enrollment Rate
Time Frame: Pre-Randomization
|
Enrollment rate calculated from data obtained from recruitment logs
|
Pre-Randomization
|
Study Attrition Rate
Time Frame: 12 months
|
Study attrition will be calculated from study logs
|
12 months
|
Monthly Intervention Calls Completed by Parent Leaders
Time Frame: 12 months
|
Percentage of monthly intervention calls completed by Parent Leaders will be determined from study logs
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Rate of Average Blood Glucose
Time Frame: Change from baseline at 12 months
|
Hemoglobin A1C from medical record
|
Change from baseline at 12 months
|
Change in Frequency of Adherence
Time Frame: Change from baseline at 12 months
|
Frequency of blood glucose monitoring obtained from blood glucose meter and the Diabetes Self-Management Questionnaire
|
Change from baseline at 12 months
|
Change in Level of Child Diabetes Quality of Life: Pediatric Quality of Life Diabetes Module
Time Frame: Change from baseline at 12 months
|
Pediatric Quality of Life Total Cumulative Scale (scores range from 0-132 with higher scores indicating worse quality of life)
|
Change from baseline at 12 months
|
Change in Level of Parent involvement in diabetes management tasks
Time Frame: Change from baseline at 12 months
|
The Diabetes Family Responsibility Questionnaire (scores range from 17-51 with lower scores indicating parent in primarily responsible for diabetes management)
|
Change from baseline at 12 months
|
Change in Level of Parent self-efficacy
Time Frame: Change from baseline at 12 months
|
Parental Self-Efficacy for Diabetes Management questionnaire scores range from 8-40 with higher scores indicating higher self-efficacy)
|
Change from baseline at 12 months
|
Change in Level of Parent diabetes emotional burden
Time Frame: Change from baseline at 12 months
|
Problem Areas in Diabetes Revised for Parents (scores range from 0-72 with higher scores indicating less emotional burden)
|
Change from baseline at 12 months
|
Change in Level of Parent Depressive Symptoms
Time Frame: Change from baseline at 12 months
|
The Center for Epidemiological Depression Studies-Depression scale (scores range from 12-48 with higher scores indicating more depressive symptoms)
|
Change from baseline at 12 months
|
Change in Level of Parent Social Support
Time Frame: Change from baseline at 12 months
|
2-way Social Support Scale total score (scores range from 0-100 with higher scores indicating more giving and receiving of social support)
|
Change from baseline at 12 months
|
Change in Degree of Impact of diabetes on the family system
Time Frame: Change from baseline at 12 months
|
Diabetes Family Impact Scale (scores range from 0-56 with higher scores indicating greater impact of diabetes on the family)
|
Change from baseline at 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ashley M Butler, PhD, Baylor College of Medicine
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-40380
- DP3DK113236 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Family Teamwork-Peer Delivery
-
Joslin Diabetes CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Jaeb...Completed
-
Joslin Diabetes CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 Diabetes MellitusUnited States
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children...Active, not recruiting
-
University of Illinois at Urbana-ChampaignPenn State UniversityCompleted
-
Fred Hutchinson Cancer CenterNational Institute of Mental Health (NIMH)RecruitingHIV PreventionKenya
-
Florida International UniversityNational Institute of Mental Health (NIMH)CompletedAnxiety DisordersUnited States
-
Washington State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
University College, LondonLondon School of Hygiene and Tropical Medicine; Africa Health Research InstituteUnknown
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingHypertension | Medication AdherenceUnited States